Verve Therapeutics Inc (VERV)
6.64
-0.02
(-0.30%)
USD |
NASDAQ |
Apr 19, 16:00
6.64
0.00 (0.00%)
After-Hours: 16:52
Verve Therapeutics Accounts Payable (Quarterly): 6.636M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.636M |
| September 30, 2023 | 1.054M |
| June 30, 2023 | 3.146M |
| March 31, 2023 | 3.372M |
| December 31, 2022 | 2.424M |
| September 30, 2022 | 0.465M |
| June 30, 2022 | 6.32M |
| Date | Value |
|---|---|
| March 31, 2022 | 2.438M |
| December 31, 2021 | 7.077M |
| September 30, 2021 | 3.579M |
| June 30, 2021 | 1.53M |
| March 31, 2021 | 2.487M |
| December 31, 2020 | 0.036M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.036M
Minimum
Dec 2020
7.077M
Maximum
Dec 2021
3.120M
Average
2.487M
Median
Mar 2021
Accounts Payable (Quarterly) Benchmarks
| Acorda Therapeutics Inc | 14.54M |
| Eli Lilly and Co | 2.599B |
| Intellia Therapeutics Inc | 7.452M |
| Beam Therapeutics Inc | 1.617M |
| Editas Medicine Inc | 8.269M |